Sudden Loss of Vision: An Insight into Rivaroxaban
Sudden Loss of Vision: An Insight into Rivaroxaban
复制标题
DOI：
10.7759/cureus.4542
复制
发表时间：
2019-04-25
影响因子：
1.2
通讯作者：
Hussain, Ishtiaq
中科院分区：
文献类型：
--
作者：
Jain, Akriti G.;Rashid, Mamoon Ur;Hussain, Ishtiaq
球后出血是一种迅速恶化的紧急情况，其特征与严重的眼眶或面部创伤有关。自发性出血进入眼球后室是罕见的。如果不及时治疗，可能导致永久性视力丧失。利伐沙班是一种直接作用的口服抗凝剂（DOAC），可抑制Xa因子，广泛用于非瓣膜性房颤（AFib）患者的卒中预防。
A retrobulbar hemorrhage is a rapidly worsening emergent condition characteristically associated with significant orbital or facial trauma. Spontaneous hemorrhage into the retrobulbar compartment is rare. If not managed in a timely manner, it can lead to permanent vision loss. Rivaroxaban is a directly acting oral anticoagulant (DOAC) that inhibits factor Xa and is widely used for stroke prevention in patients with non-valvular atrial fibrillation (AFib).